Gengos Andrew Insider Trades

Insider Trading History

Track insider trading activity for Gengos Andrew. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
May 05, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$50.6M 956,250 shares
$52.97
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
May 05, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$2.15M 40,503 shares
$53.00
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Chief Financial Officer
Holding Value $7.28M 137,500 shares
Last Trade
Jan 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.67M 206,250 shares
$37.18
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Chief Financial Officer
Holding Value $1.32M 25,000 shares
Last Trade
Jun 27, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$19.7k 5,000 shares
$3.93
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Chief Financial Officer
Holding Value $794k 15,000 shares
Last Trade
Jun 16, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$19.8k 5,000 shares
$3.95
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Chief Financial Officer
Holding Value $530k 10,000 shares
Last Trade
Jun 13, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$18.6k 5,000 shares
$3.72
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Chief Financial Officer
Holding Value $39.7M 750,000 shares
Last Trade
Feb 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.8M 750,000 shares
$3.73
$52.95
Athira Pharma
Athira Pharma ATHA
CFO And Chief Business Officer
Holding Value $658k 97,532 shares
Last Trade
Sep 05, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$725 1,272 shares
$0.57
$6.75
Athira Pharma
Athira Pharma ATHA
CFO And Chief Business Officer
Holding Value $667k 98,804 shares
Last Trade
Sep 03, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.2k 5,000 shares
$2.83
$6.75
Athira Pharma
Athira Pharma ATHA
CFO And Chief Business Officer
Holding Value $633k 93,804 shares
Last Trade
May 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25.2k 10,000 shares
$2.52
$6.75
Athira Pharma
Athira Pharma ATHA
CFO AND CHIEF BUSINESS OFFICER
Holding Value $1.89M 280,000 shares
Last Trade
Feb 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$913k 280,000 shares
$3.26
$6.75
Athira Pharma
Athira Pharma ATHA
CFO AND CHIEF BUSINESS OFFICER
Holding Value $566k 83,804 shares
Last Trade
Jan 05, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.52k 1,208 shares
$2.91
$6.75
Athira Pharma
Athira Pharma ATHA
CFO AND CHIEF BUSINESS OFFICER
Holding Value $574k 85,012 shares
Last Trade
Jan 04, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.7k 5,000 shares
$3.13
$6.75
Athira Pharma
Athira Pharma ATHA
See Below
Holding Value $540k 80,012 shares
Last Trade
Jun 07, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$51.5k 15,000 shares
$3.43
$6.75
Athira Pharma
Athira Pharma ATHA
See Below
Holding Value $439k 65,012 shares
Last Trade
Jun 05, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$30.2k 10,000 shares
$3.02
$6.75
Athira Pharma
Athira Pharma ATHA
See Below
Holding Value $566k 83,804 shares
Last Trade
Jan 05, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.12k 1,208 shares
$3.41
$6.75
Athira Pharma
Athira Pharma ATHA
See Below
Holding Value $574k 85,012 shares
Last Trade
Jan 04, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.9k 5,000 shares
$3.57
$6.75
Cyteir Therapeutics
Cyteir Therapeutics CYT
Chief Business Officer
Holding Value $106k 35,000 shares
Last Trade
Feb 22, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$209k 35,000 shares
$5.96
$3.02
Cyteir Therapeutics
Cyteir Therapeutics CYT
Chief Business Officer
Holding Value $222k 73,534 shares
Last Trade
Jun 17, 2021 Sale
No data
No data
$3.02
Synlogic
Synlogic SYBX
Chief Operating Officer
Holding Value $7k 10,000 shares
Last Trade
Mar 14, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.49M 10,000 shares
$149.25
$0.70

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up